June 10, 2026
Headlines

AvenCell Raises $112 Million to Revolutionize Cancer Treatment with New Cell Therapy Technology

Editor05 mins

In a significant boost for cancer therapy innovation, AvenCell Therapeutics, Inc. has announced the successful closure of a $112 million Series B funding round. The financing, spearheaded by Novo Holdings, attracted new investors including F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, and NYBC Ventures, alongside existing backer Blackstone Life Sciences. This funding…

Read More

Antora Energy Secures $14.5 Million ARPA-E Award to Propel Industrial Decarbonization Efforts

Editor06 mins

Antora Energy, a pioneering force in zero-emissions industrial heat and power solutions, has been awarded up to $14.5 million by the Department of Energy’s ARPA-E program. This funding, facilitated through the SCALEUP initiative, aims to accelerate the deployment of Antora’s innovative combined heat and power thermal battery product. Following earlier support from ARPA-E, this capital…

Read More

Cult Mia Secures $5 Million in Seed Funding Amid Triple-Digit Growth

Editor05 mins

In a remarkable demonstration of confidence from investors, UK-based luxury retail platform Cult Mia has successfully raised an additional $2 million, bringing its total seed funding to $5 million. This latest round builds upon an initial $3 million raise completed in November 2023, led by Fuel Ventures with notable participation from Morgan Stanley and David…

Read More

PictorLabs Secures $30 Million in Series B Funding to Revolutionize Histopathology with AI

Editor05 mins

PictorLabs, an innovative software firm at the forefront of AI-driven histopathology, has successfully raised $30 million in its Series B funding round. This round was led by Insight Partners, a global software investment powerhouse, with continued support from M Ventures, the venture capital branch of Merck KGaA, Darmstadt, Germany, which previously led PictorLabs’ Series A…

Read More

Cardurion Pharmaceuticals Secures $260 Million Series B to Advance Cardiovascular Drug Pipeline

Editor04 mins

Cardurion Pharmaceuticals, a pioneering biotechnology firm specializing in innovative therapies for cardiovascular diseases, has announced the successful completion of a $260 million Series B financing round. Led by Ascenta Capital and supported by a consortium of esteemed investors including NEA, GV, and Fidelity Management & Research Company, this substantial funding underscores Cardurion’s commitment to advancing…

Read More

DreamBig Raises $75M in Series B Funding to Expand AI and Data Center Solutions

Editor05 mins

DreamBig Semiconductor Inc., a trailblazer in high-performance accelerator platforms, announced today the successful closure of a $75 million Series B funding round. Co-led by the Samsung Catalyst Fund and the Sutardja Family, this investment is set to propel the company’s innovative Chiplet Hub™ technology and platform chiplets into new frontiers of AI inference and training….

Read More

Fellos Raises €2.15M to Redefine Men’s Health in the Digital Age

Editor07 mins

In a move that underscores growing momentum in telehealth, Fellos, a digital clinic focused on men’s health, has raised approximately €2.15 million in growth capital. The funding round drew in a cohort of strategic backers, including healthcare professionals, Dutch Operator Fund, and Capital Mills, propelling Fellos further on its mission to make essential men’s health…

Read More

Nature Takes Center Stage: Natcap Secures $10 Million to Integrate Nature into Business Decisions

Editor04 mins

In a significant win for environmental awareness, Natcap, a pioneering nature intelligence company, has secured $10 million in an oversubscribed Series A funding round. This impressive feat, achieved amidst a challenging global fundraising environment, underscores the growing recognition of nature’s critical role in business strategy. The funding round, led by prominent figures like André Hoffmann…

Read More

Private 5G’s Missing Link: OneLayer Raises $28 Million to Simplify Enterprise Cellular Networks

Editor05 mins

As enterprises rush to harness the transformative potential of private LTE and 5G networks, complexity threatens to stall adoption. OneLayer, a Boston-based startup helmed by CEO and co-founder Dave Mor, is staking its claim as the essential infrastructure enabler that bridges cellular technology and enterprise IT. Closing a $28 million Series A round led by…

Read More

NephroDI Therapeutics Secures Strategic Investment to Propel Innovative Therapy for Pediatric Kidney Disease

Editor04 mins

NephroDI Therapeutics (NephroDI), a leading near-clinical stage pharmaceutical company specializing in kidney disorders, proudly announces a significant Series A investment from life sciences venture capital firm Sound Bioventures. This latest infusion of capital, in tandem with a previously established strategic corporate partnership, is set to advance the development of NDI-5001, a groundbreaking small molecule AMPK…

Read More